✦ LIBER ✦

Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide

✍ Scribed by H. Anderson; M. J. Lind; N. Thatcher; R. Swindell; A. Woodcock; K. B. Carroll

Publisher: Springer
Year: 1990
Tongue: English
Weight: 319 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02940299

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, etoposide, and thoracic irra

Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer

✍ Nick Thatcher; Tom Cerny; Ron Stout; Heather Anderson; Philip V. Barber; Roger J 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

Amrubicin for treating elderly and poor-

Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer

✍ Satoshi Igawa; Shinichiro Ryuge; Tomoya Fukui; Sakiko Otani; Yuka Kimura; Ken Ka 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 265 KB

Double alkylating agent therapy with ifo

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group

✍ Nick Thatcher; David B. Smith; Mike J. Lind; Heather Anderson; Joyce Barclay; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

A randomized trial to compare intravenou

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

✍ David H. Johnson; John C. Ruckdeschel; James H. Keller; Gary H. Lyman; Gerald J. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Definitive radiation therapy for medical

Definitive radiation therapy for medically inoperable patients with stage I and II non-small cell lung cancer

✍ Kazushige Hayakawa; Norio Mitsuhashi; Yoshihiro Saito; Yuko Nakayama; Susumu Kat 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The treatment results of 84 patients with clinical stage I and II non-small cell lung cancer (NSCLC) treated with definitive radiation therapy (RT) alone at Gunma University Hospital from 1976 through 1989 were retrospectively analyzed. All patients were treated with 10 M V X-rays using anteroposter

A phase II study of cisplatin, oral admi

A phase II study of cisplatin, oral administration of etoposide, OK-432 and radiation therapy for inoperable stage III non-small cell lung cancer

✍ Y. Mariya; M. Aoki; Y. Abe; J. Takahashi; H. Fukuda; S. Ono; S. Yoshioka; T. Aka 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 564 KB